Category: Migration (25)

Order by:
<< | < | 1 2 3 | > | >>


Parathyroid Hormone Mobilizes Stem Cells

Boston, USA - Stem cell mobilizing agents are conventionally used to increase the number of circulating stem cells in peripheral blood so that these stem cells can be harvested and used for transplantation, either in an autologous, or allogeneic manner. Nutritional companies have capitalized on the possibility of mobilizing stem cells by various supplements so as...

Tuesday August 21st, 2007 @ 19:36:50 EST

Hyaluronic Acid Mediated Mesenchymal Stem Cell Migration

Much is known about CD34+ stem cell migration to areas of hypoxia due to secretion of SDF-1 (CXCL12) by the hypoxia tissue. Migration towards the CXCL12 gradient has been documented in diverse situations ranging from post-myocardial infarction CD34 mobilization to homing of hematopoietic...

Saturday August 4th, 2007 @ 11:24:13 EST

Stroke Calls Stem Cells

Nice, France - It is known that after myocardial infarction stem cells exit the bone marrow and enter systemic circulation, possibly as a response to chemoattractants released by injured myocardium. In a recent study (Dunac et al. Neurological and functional recovery in human stroke are associated with peripheral blood CD34+ cell mobilization. J Neurol. 2007...

Wednesday August 1st, 2007 @ 19:17:56 EST

Stem Cell Cancer Therapy

Bratislava, Slovakia - Various types of stem cells are known to home specifically into neoplastically transformed tissue. In a recent paper (Kucerova et al. Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res. 2007 Jul 1;67(13):6304-13) this property was leveraged in order to...

Thursday July 12th, 2007 @ 16:05:51 EST

Telling Mesenchymal Stem Cells Where to Go

Birmingham, Alabama, USA - Stem cell migration is an important issue. In situations like bone marrow transplantation for hematpoietic reconstitution, the hematopoietic stem cells are "told" to home to the bone marrow of the recipient by virtue of molecules such as SDF-1 which are...


Why Sorted CXCR4+ and CXCR4- Stem Cells Have Similar Engraftment

[Watch the Video] This video reviews data that explains why CXCR4+ stem cells and CXCR4- stem cells home with similar efficiency to the bone marrow. The answer is that the CXCR4 antibody actually blocks signalling, and that CXCR4- cells actually contain intracellular stores of...

Sunday July 8th, 2007 @ 14:43:34 EST 1 Comment

Accelerating Mesenchymal Stem Cell Migration

Beijing, China - Mesenchymal stem cells are currently being explored by companies such as pluristem for the acceleration of bone marrow hematopoietic stem cell engraftment after transplantation. In a recent study (Shi et al. Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in Friday July 6th, 2007 @ 01:59:15 EST


Seaweed mobilization of stem cells

Hobart, Australia - Stem cell mobilization from the bone marrow is clinically performed by administration of cytokines such as G-CSF in order to collect peripheral blood stem cells, primarily for the purposes of bone marrow transplant. Other newer uses include the mobilization of stem cells in order to accelerate healing of cardiac infarcts, as well as induction of angiogenesis by...

Friday June 1st, 2007 @ 04:02:29 EST 2 Comments

Calling All Stem Cells !!!

Minneapolis, Minnesota - It is known that subsequent to cardiac infarction, various cytokines are produced by the injured myocardium that mobilize endogenous stem cells from the bone marrow into systemic circulation, and specifically "calling" them to home to the ischemic tissue. Unfortunately, this process occurs only to a small extent and full repair of the myocardium after injury...

Friday May 25th, 2007 @ 20:40:39 EST

Endotoxin decreases circulating EPC

Vienna, Austria - Circulating endothelial progenitor cell levels have been reported to increase with exercise, smoking cessation, as well as taking statin drugs...amongst other things. In a recent paper it was demonstrated that endotoxin induces a temporary (24 hr) decrease in the number of circulating endothelial progenitors (Mayr et al. Effects of low dose endotoxemia on endothelial...

Monday May 14th, 2007 @ 14:32:08 EST

Order by:
<< | < | 1 2 3 | > | >>





Home | News | Patents | Products | Journal | Jobs | Search | RSS

About | Advisory Board | Newsletter | Advertise | Contact | Sitemap | Privacy Policy | Terms of Use

Copyright © 2006 - 2008 StemCellPatents.com - All rights reserved. - Toronto Web Design

StemCellPatents.com V2.01